Unveiling mechanisms of relapse in small cell lung cancer under therapy

Small cell lung cancer (SCLC) is a highly aggressive tumor of the lung that occurs especially in heavy smokers.

Gene therapy shows promise for arrhythmogenic cardiomyopathy

Researchers evaluated the effectiveness of adeno-associated virus (AAV)-mediated Plakophilin 2 (PKP2) delivery in treating arrhythmogenic cardiomyopathy (ACM).

December 12, 2023

Otsuka, ShapeTX to develop gene therapies for eye diseases

The companies will develop gene therapies for ocular diseases under the new deal. Credit: elenavolf / Shutterstock.com. Otsuka Pharmaceutical has entered a multi-target partnership with

September 8, 2023

AI-based applications for personalized cancer medicine and related regulatory challenges: An overview

Personalized therapies could improve the treatment of many diseases in the future. Cancer medicine in particular has made significant progress in recent years.

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.